Cornelia Ulrich

Cornelia "Neli" Ulrich (born 31 October 1967 in Stuttgart-Bad Cannstatt, Germany) is Executive Director of the Comprehensive Cancer Center at Huntsman Cancer Institute (HCI), Jon M. and Karen Huntsman Presidential Professor in Cancer Research, and former Division Chief of Cancer Population Sciences in the Department of Population Health Sciences at the University of Utah.[1][2][3] Dr. Ulrich oversees HCI's academic consortium of nearly 200 cancer research teams. She leads efforts to advance the impact of HCI's research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment. Prior to joining HCI, she was the Director and Head of the Department of Preventive Oncology at the National Center of Tumor Diseases [4](NCT) and German Cancer Research Center (DKFZ) in Heidelberg. In this time, she also held a Professorship at the DKFZ and University of Heidelberg. From 1993 until 2009, Ulrich was a Member of the Fred Hutchinson Cancer Research Center and Professor in Epidemiology at the University of Washington in Seattle.

Dr. Ulrich has published more than 350 publications (h-Index 68).[5] Ulrich is a former Fulbright Scholar, DAAD Scholar,[6] and an elected member[7] to the European Academy of Cancer Sciences; she serves on numerous national and international advisory boards, committees, and editorial boards including several of the National Institutes of Health, National Academy of Sciences, Engineering and Medicine, International Agency for Research on Cancer (IARC) and American Association of Cancer Research (AACR), and was chair of the Scientific Council of IARC until May 2015. Her research group focuses on lifestyle and biologic factors in cancer prevention and cancer prognosis, particularly colorectal cancer. Key topics include the usage of inflammation inhibitors (e.g., aspirin) in cancer prevention and prognosis.[8][9][10] to prevent cancer, personalized medicine by using pharmacogenetics, and the role of energy balance and physical activity.[11][12][13] Dr. Ulrich is also Principal Investigator of the HCI Total Cancer Care Protocol in the ORIEN network of cancer centers.

Life and education

Dr. Ulrich graduated in 1987 from the Gustav-Stresemann-Gymnasium in Fellbach, Germany and studied Nutritional Sciences at the University of Hohenheim and the Oregon State University. She completed her master's degree in 1992 at Oregon State University. In 1998 she completed her PhD in Epidemiology at the University of Washington and the Fred Hutchinson Cancer Research Center. She is married and mother of two sons.

Honors and awards
  • 1991/92: Fulbright Scholarship and Fulbright Professional Enhancement Grant
  • 1992: Jewell-Fields-Rohlfing graduate scholarship, Oregon State University
  • 1993–95: DAAD Stipendium, für PhD-Studien in Epidemiologie[6]
  • 1998: Outstanding Student Award, Department of Epidemiology, University of Washington
  • 1998: American Association of Cancer Research Bristol-Myers Squibb Young Investigator Awardhttps://sharedresources.fredhutch.org/profile/ulrich-cornelia
  • 2009: Exzellenzprofessur, Deutsches Krebsforschungszentrum (DKFZ)
  • 2011: Forschungs- und Entwicklungspreis 2011, Krebsverband Baden-Württemberg e.V.
  • 2013: Felix Burda Award 2013, „Best Prevention Idea“, Felix Burda Stiftung, Berlin[14]
  • 2014: Short-List Felix Burda Award 2014, „Wissenschaft und Science“, Felix Burda Stiftung, Berlin
  • 2014: Jon and Karen Huntsman Presidential Professor in Cancer Research
  • 2018: National Academy of Medicine Annual Meeting Presentation
  • 2019: Executive Leadership in Academic Medicine (ELAM) Program

References
  1. "Department of Population Health Sciences - U of U School of Medicine - | University of Utah". medicine.utah.edu. Retrieved 2017-10-05.
  2. "Principal Investigator - Neli Ulrich, MS, PhD Salt Lake City, Utah". healthcare.utah.edu. Retrieved 2017-12-05.
  3. "Cancer Control and Population Sciences Salt Lake City, Utah". healthcare.utah.edu. Retrieved 2017-10-05.
  4. Heidelberg, NCT Nationales Centrum für Tumorerkrankungen. "NCT Nationales Centrum für Tumorerkrankungen Heidelberg". www.nct-heidelberg.de (in German). Retrieved 2017-10-05.
  5. "My Bibliography - My NCBI Collection". www.ncbi.nlm.nih.gov. Retrieved 2017-10-05.
  6. Austauschdienst, DAAD - Deutscher Akademischer. "Prof. Dr. Cornelia Ulrich - DAAD - Deutscher Akademischer Austauschdienst". www.daad.de. Retrieved 2017-10-05.
  7. "Fellows| European Academy of Cancer Sciences". www.europeancanceracademy.eu. Retrieved 2017-10-05.
  8. DI, Brixner; Al., Et (December 4, 2017). "Aspirin and Cancer Risk". JAMA Oncology. 2 (10): 1370–1371. doi:10.1001/jamaoncol.2016.2308. PMID 27533476.
  9. Nan, Hongmei; Hutter, Carolyn M.; Lin, Yi; Jacobs, Eric J.; Ulrich, Cornelia M.; White, Emily; Baron, John A.; Berndt, Sonja I.; Brenner, Hermann (2015-03-17). "Association of aspirin and non-steroidal anti-inflammatory drug use with risk of colorectal cancer according to genetic variants". JAMA. 313 (11): 1133–1142. doi:10.1001/jama.2015.1815. ISSN 0098-7484. PMC 4382867. PMID 25781442.
  10. Barry, Elizabeth L.; Poole, Elizabeth M.; Baron, John A.; Makar, Karen W.; Mott, Leila A.; Sandler, Robert S.; Ahnen, Dennis J.; Bresalier, Robert S.; McKeown-Eyssen, Gail E.; Ulrich, Cornelia M. (August 29, 2015). "CYP2C9 Variants Increase Risk of Colorectal Adenoma Recurrence and Modify Associations with Smoking but Not Aspirin Treatment". Cancer Causes & Control. 24 (1): 47–54. doi:10.1007/s10552-012-0088-6. PMC 3529799. PMID 23081681.
  11. Schmidt, Martina E.; Wiskemann, Joachim; Armbrust, Petra; Schneeweiss, Andreas; Ulrich, Cornelia M.; Steindorf, Karen (2015-07-15). "Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial". International Journal of Cancer. 137 (2): 471–480. doi:10.1002/ijc.29383. ISSN 1097-0215. PMID 25484317.
  12. Steindorf, K.; Schmidt, M. E.; Klassen, O.; Ulrich, C. M.; Oelmann, J.; Habermann, N.; Beckhove, P.; Owen, R.; Debus, J. (November 2014). "Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life". Annals of Oncology. 25 (11): 2237–2243. doi:10.1093/annonc/mdu374. ISSN 1569-8041. PMID 25096607.
  13. Potthoff, Karin; Schmidt, Martina E; Wiskemann, Joachim; Hof, Holger; Klassen, Oliver; Habermann, Nina; Beckhove, Philipp; Debus, Juergen; Ulrich, Cornelia M (2013-03-28). "Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study". BMC Cancer. 13: 162. doi:10.1186/1471-2407-13-162. ISSN 1471-2407. PMC 3617011. PMID 23537231.
  14. "Die Preisträger | Felix Burda Stiftung". www.felix-burda-stiftung.de (in German). Retrieved 2017-10-05.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.